Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Novel compound heterozygous ABCA2 variants cause IDPOGSA, a variable phenotypic syndrome with intellectual disability

Abstract

The gene for ATP binding cassette subfamily A member 2 (ABCA2) is located at chromosome 9q34.3. Biallelic ABCA2 variants lead to intellectual developmental disorder with poor growth and with or without seizures or ataxia (IDPOGSA). In this study, we identified novel compound heterozygous ABCA2 variants (NM_001606.5:c.[5300–17C>A];[6379C>T]) by whole exome sequencing in a 28-year-old Korean female patient with intellectual disability. These variants included intronic and nonsense variants of paternal and maternal origin, respectively, and are absent from gnomAD. SpliceAI predicted that the intron variant creates a cryptic acceptor site. Reverse transcription-PCR using RNA extracted from a lymphoblastoid cell line of the patient confirmed two aberrant transcripts. Her clinical features are compatible with those of IDPOGSA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2

Data availability

The data of this study are not publicly available due to concerns regarding patient anonymity. Requests to access the data should be directed to the corresponding author. Only anonymized data are available to researchers upon request.

References

  1. Kim WS, Weickert CS, Garner B. Role of ATP-binding cassette transporters in brain lipid transport and neurological disease. J Neurochem. 2008;104:1145–66.

    Article  CAS  PubMed  Google Scholar 

  2. Albrecht C, Viturro E. The ABCA subfamily-gene and protein structures, functions and associated hereditary diseases. Pflug Arch. 2007;453:581–9.

    Article  CAS  Google Scholar 

  3. Maddirevula S, Alzahrani F, Al-Owain M, Al Muhaizea MA, Kayyali HR, AlHashem A, et al. Autozygome and high throughput confirmation of disease genes candidacy. Genet Med. 2019;21:736–42.

    Article  CAS  PubMed  Google Scholar 

  4. Hu H, Kahrizi K, Musante L, Fattahi Z, Herwig R, Hosseini M, et al. Genetics of intellectual disability in consanguineous families. Mol Psychiatry. 2019;24:1027–39.

    Article  CAS  PubMed  Google Scholar 

  5. Bruel AL, Nambot S, Quéré V, Vitobello A, Thevenon J, Assoum M, et al. Increased diagnostic and new genes identification outcome using research reanalysis of singleton exome sequencing. Eur J Hum Genet. 2019;27:1519–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Aslam F, Naz S. Ataxia and dysarthria due to an ABCA2 variant: Extension of the phenotypic spectrum. Parkinsonism Relat Disord. 2019;64:328–31.

    Article  PubMed  Google Scholar 

  7. Seyama R, Uchiyama Y, Kaneshi Y, Hamanaka K, Fujita A, Tsuchida N, et al. Distal arthrogryposis in a girl arising from a novel TNNI2 variant inherited from paternal somatic mosaicism. J Hum Genet. 2023;68:363–7.

    Article  CAS  PubMed  Google Scholar 

  8. Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, McRae JF, Darbandi SF, Knowles D, et al. Predicting Splicing from Primary Sequence with Deep Learning. Cell. 2019;176:535–48.e524.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We would like to thank the patient and her family for their participation in this study. We are also grateful to Ms. Sayaka Sugimoto, Ms. Mai Sato, Ms. Nobuko Watanabe, Ms. Kaori Takabe, and Mr. Takafumi Miyama at the Department of Human Genetics, Yokohama City University Graduate School of Medicine for their excellent technical assistance. We thank Rachel James, PhD, from Edanz (https://jp.edanz.com/ac) for editing a draft of this manuscript.

Funding

This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant numbers JP23ek0109674, JP23ek0109549, JP23ek0109617, JP23ek0109648 to N. Matsumoto); the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid for Scientific Research (grant numbers JP20K17936 and JP22K15901 to A. Fujita, JP23H02829 to S. Miyatake, JP23H02877 to T. Mizuguchi, JP22K15901 to K. Hamanaka, JP23K07229 to Y. Uchiyama, JP23K15353 to N. Tsuchida, and JP21K07869 to E. Koshimizu); the Takeda Science Foundation (T. Mizuguchi and N. Matsumoto); and Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (S. Miyatake).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Naomichi Matsumoto.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Inoue, Y., Tsuchida, N., Kim, C.A. et al. Novel compound heterozygous ABCA2 variants cause IDPOGSA, a variable phenotypic syndrome with intellectual disability. J Hum Genet 69, 163–167 (2024). https://doi.org/10.1038/s10038-024-01219-8

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s10038-024-01219-8

This article is cited by

Search

Quick links